Bioteque (4107) - Total Assets
Based on the latest financial reports, Bioteque (4107) holds total assets worth NT$4.81 Billion TWD (≈ $151.41 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Bioteque - Total Assets Trend (2006–2025)
This chart illustrates how Bioteque's total assets have evolved over time, based on quarterly financial data. Also see how much is Bioteque worth for the company's overall valuation and market capitalisation.
Bioteque - Asset Composition Analysis
Current Asset Composition (December 2025)
Bioteque's total assets of NT$4.81 Billion consist of 50.1% current assets and 49.9% non-current assets. Review Bioteque total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 24.9% |
| Accounts Receivable | NT$243.68 Million | 5.2% |
| Inventory | NT$294.36 Million | 6.3% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2006–2025)
This chart illustrates how Bioteque's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for Bioteque for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bioteque's current assets represent 50.1% of total assets in 2025, an increase from 43.0% in 2006.
- Cash Position: Cash and equivalents constituted 24.9% of total assets in 2025, up from 0.0% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2006.
- Asset Diversification: The largest asset category is inventory at 6.3% of total assets.
Bioteque Competitors by Total Assets
Key competitors of Bioteque based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Tinavi Medical Technologies Co Ltd
SHG:688277
|
China | CN¥1.64 Billion |
|
Mark Dynamics Indonesia Tbk PT
JK:MARK
|
Indonesia | Rp980.33 Billion |
|
Interojo Inc
KQ:119610
|
Korea | ₩252.22 Billion |
|
Daxor Corporation
NASDAQ:DXR
|
USA | $35.90 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
Bioteque - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.53 | 2.51 | 4.30 |
| Quick Ratio | 2.22 | 2.19 | 3.70 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$1.48 Billion | NT$1.42 Billion | NT$1.67 Billion |
Bioteque - Advanced Valuation Insights
This section examines the relationship between Bioteque's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.35 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | 0.3% |
| Total Assets | NT$4.66 Billion |
| Market Capitalization | $243.43 Million USD |
Valuation Analysis
Below Book Valuation: The market values Bioteque's assets below their book value (0.05x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Bioteque's assets grew by 0.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Bioteque (2006–2025)
The table below shows the annual total assets of Bioteque from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | NT$4.66 Billion ≈ $146.82 Million |
+0.31% |
| 2024-12-31 | NT$4.65 Billion ≈ $146.36 Million |
+0.54% |
| 2023-12-31 | NT$4.62 Billion ≈ $145.57 Million |
+3.12% |
| 2022-12-31 | NT$4.48 Billion ≈ $141.16 Million |
+16.05% |
| 2021-12-31 | NT$3.86 Billion ≈ $121.64 Million |
+8.34% |
| 2020-12-31 | NT$3.56 Billion ≈ $112.28 Million |
+21.20% |
| 2019-12-31 | NT$2.94 Billion ≈ $92.64 Million |
+6.10% |
| 2018-12-31 | NT$2.77 Billion ≈ $87.32 Million |
+5.72% |
| 2017-12-31 | NT$2.62 Billion ≈ $82.59 Million |
+2.25% |
| 2016-12-31 | NT$2.56 Billion ≈ $80.77 Million |
+2.40% |
| 2015-12-31 | NT$2.50 Billion ≈ $78.88 Million |
+6.69% |
| 2014-12-31 | NT$2.35 Billion ≈ $73.94 Million |
+17.52% |
| 2013-12-31 | NT$2.00 Billion ≈ $62.92 Million |
+22.78% |
| 2012-12-31 | NT$1.63 Billion ≈ $51.24 Million |
-0.11% |
| 2011-12-31 | NT$1.63 Billion ≈ $51.30 Million |
-3.37% |
| 2010-12-31 | NT$1.69 Billion ≈ $53.09 Million |
-2.44% |
| 2009-12-31 | NT$1.73 Billion ≈ $54.41 Million |
+0.31% |
| 2008-12-31 | NT$1.72 Billion ≈ $54.25 Million |
+4.28% |
| 2007-12-31 | NT$1.65 Billion ≈ $52.02 Million |
+26.11% |
| 2006-12-31 | NT$1.31 Billion ≈ $41.25 Million |
-- |
About Bioteque
Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company offers angiography catheter, balloon dilation catheter, guiding sheath, guide steel wire, y-type connector, multi-pipe joint, connecting pipe, y-type connector assembly, peripheral vascular guiding catheter, coronary balloon dilation catheter, central venous catheter… Read more